Cell No. : Cell Name
RCB0439 : LC-1F update : 2024/12/05 |
||||
Comment | Human cell line derived from lung cancer. Squamous cell carcinoma. Floating cells (non-adherent cells). LC-1/sq-SF (RCB0438), LC-1F (RCB0439), and LC-1/sq (RCB0455) are derived from the same patient. | |||
Comment from the depositor | ||||
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. | |||
Remarks | ||||
Order Form | Order Form(C-0005.pdf) MTA(C-0007.pdf) MTA(C-0007p.pdf) | |||
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp). | ||||
Basic information | Depositor | Itoh, Hiroshi | ||
Originator | Kataoka, Hiroaki | |||
Year of deposit | 1989 | |||
Original cell | LC-1/sq | |||
Animal | _human < Mammals | |||
Genus | Homo | |||
Species | sapiens | |||
Race | Japanese | |||
Gender | Male | |||
Age at sampling | 69 years | |||
Tissue | lung | |||
Classification | cancer | |||
Year of origin | 1986 | |||
History | H. Kataoka | |||
Memo_1 | Mycoplasma was eliminated with MC-210. | |||
Lifespan | infinite | |||
Morphology | other | |||
Cellosaurus(Expasy) | CVCL_1372 | |||
Medium | Medium List | |||
Culture type | Suspension cells | |||
Culture method | General Guidelines for Culturing Suspension Cells, 浮遊細胞の培養に関する一般的な注意(Japanese) | |||
Culture medium | (HamF12 : RPMI1640 = 1 : 1) + 25mM HEPES + 10% FBS | |||
Antibiotics | Free | |||
Passage method | dilution | |||
Culture information | Passage ratio | 1 : 4 split | ||
SC frequency | Subculture : once/week, Medium Renewal : 2 times/week | |||
Temperature | 37 ℃ | |||
CO2 concentration | 5 % | |||
Freeze medium | Medium + 10% DMSO | |||
Freezing method | Slow freezing | |||
Mycoplasma/Acholeplasma | (-) | |||
Virus (HIV) | (-) | |||
Isozyme | LD, NP | |||
Chromosome mode | 73-181(50) : /83(5),84(1),85(11),86(5),87(3),88(2)/ | |||
STR(human) | OK | |||
Images | ||||
|
|
|||
Reference information | Reference | 1 | ||
User's Publication | 9 | |||
Reference |
1779 Itoh H, Kataoka H, Koita H, Nabeshima K, Inoue T, Kangawa K, Koono M Establishment of a new human cancer cell line secreting protease nexin-II/amyloid beta protein precursor derived from squamous-cell carcinoma of lung. Int J Cancer 1991 49:436-43 PubMed ID: 1917142 DOI: 10.1002/ijc.2910490322 |
User's Publication |
13332 Hase H, Aoki M, Matsumoto K, Nakai S, Nagata T, Takeda A, Ueda K, Minami K, Kitae K, Jingushi K, Ueda Y, Yamamoto M, Furukawa T, Sato M, Tsujikawa K. Cancer type‑SLCO1B3 promotes epithelial‑mesenchymal transition resulting in the tumour progression of non‑small cell lung cancer. Oncol Rep 2021 PubMed ID: 33155667 DOI: 10.3892/or.2020.7839 |
13773 Saigusa D, Motoike IN, Saito S, Zorzi M, Aoki Y, Kitamura H, Suzuki M, Katsuoka F, Ishii H, Kinoshita K, Motohashi H, Yamamoto M. Impacts of NRF2 activation in non-small-cell lung cancer cell lines on extracellular metabolites Cancer Sci 2020 111(2):667-678 PubMed ID: 31828882 DOI: 10.1111/cas.14278 |
19029 Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, Kishimoto T, Sekihara H, Nakamura Y, Suzuki H, Forrest AR, Hayashizaki Y. LRRN4 and UPK3B are markers of primary mesothelial cells PLoS One 2011 6(10):e25391 PubMed ID: 21984916 DOI: 10.1371/journal.pone.0025391 |
6410 Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y. Is parainfluenza virus a threatening virus for human cancer cell lines? Hum Cell 2009 22(3):81-4 PubMed ID: 19624309 DOI: 10.1111/j.1749-0774.2009.00071.x |
18072 Cheng CM, Tsuneyama K, Matsui K, Takahashi H, Ishizawa S, Takano Y. Cytoplasmic expression of c-erbB2 in non-small cell lung cancers Virchows Arch 2005 446(6):596-603 PubMed ID: 15902485 DOI: 10.1007/s00428-005-1258-7 |
16489 Seike M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S, Hirohashi S. Proteomic signatures for histological types of lung cancer Proteomics 2005 5(11):2939-48 PubMed ID: 15996008 DOI: 10.1002/pmic.200401166 |
3338 Seike, Masahiro, Kondo, Tadashi, Fujii, Kazuyasu, Yamada, Tesshi, Gemma, Akihiko, Kudoh, Shoji, Hirohashi, Setsuo Proteomic signature of human cancer cells. Proteomics 2004 4:2776-88 PubMed ID: 15352251 DOI: 10.1002/pmic.200300795 |
16491 Nakanishi H, Suda T, Katoh M, Watanabe A, Igishi T, Kodani M, Matsumoto S, Nakamoto M, Shigeoka Y, Okabe T, Oshimura M, Shimizu E. Loss of imprinting of PEG1/MEST in lung cancer cell lines Oncol Rep 2004 12(6):1273-8 PubMed ID: 15547750 |
3134 Yoshimasu, T. et al Integrins α2β1,α5β1 and αvβ5 are related to tumor growth and metastasis of non-small cell cancer Japanese Journal of Lung Cancer 2001 41:111-115 DOI: 10.2482/haigan.41.111 |